TY - JOUR
T1 - Mapping the Anopheles gambiae odorant binding protein 1 (AgamOBP1) using modeling techniques, site directed mutagenesis, circular dichroism and ligand binding assays
AU - Rusconi, B.
AU - Maranhao, A. C.
AU - Fuhrer, J. P.
AU - Krotee, P.
AU - Choi, S. H.
AU - Grun, F.
AU - Thireou, T.
AU - Dimitratos, S. D.
AU - Woods, D. F.
AU - Marinotti, O.
AU - Walter, M. F.
AU - Eliopoulos, E.
N1 - Funding Information:
We acknowledge the late Dr. Harald Biessmann (Developmental Biology Center, University of California Irvine), for kindly providing the AgamOBP1 gene. This work was supported by funding from the European Commission for the FP7- HEALTH-2007-2.3.2.9 project “ ENAROMaTIC ” and the US National Institutes of Health for grants R56AI05148-6A1 and RAI051485.
PY - 2012/8
Y1 - 2012/8
N2 - The major malaria vector in Sub-Saharan Africa is the Anopheles gambiae mosquito. This species is a key target of malaria control measures. Mosquitoes find humans primarily through olfaction, yet the molecular mechanisms associated with host-seeking behavior remain largely unknown. To further understand the functionality of A. gambiae odorant binding protein 1 (AgamOBP1), we combined in silico protein structure modeling and site-directed mutagenesis to generate 16 AgamOBP1 protein analogues containing single point mutations of interest. Circular dichroism (CD) and ligand-binding assays provided data necessary to probe the effects of the point mutations on ligand binding and the overall structure of AgamOBP1. Far-UV CD spectra of mutated AgamOBP1 variants displayed both substantial decreases to ordered α-helix structure (up to22%) and increases to disordered α-helix structure(up to 15%) with only minimal changes in random coil (unordered) structure. In mutations Y54A, Y122A and W114Q, aromatic side chain removal from the binding site significantly reduced N-phenyl-1-naphthylamine binding. Several non-aromatic mutations (L15T, L19T, L58T, L58Y, M84Q, M84K, H111A, Y122A and L124T) elicited changes to protein conformation with subsequent effects on ligand binding. This study provides empirical evidence for the in silico predicted functions of specific amino acids in AgamOBP1 folding and ligand binding characteristics.
AB - The major malaria vector in Sub-Saharan Africa is the Anopheles gambiae mosquito. This species is a key target of malaria control measures. Mosquitoes find humans primarily through olfaction, yet the molecular mechanisms associated with host-seeking behavior remain largely unknown. To further understand the functionality of A. gambiae odorant binding protein 1 (AgamOBP1), we combined in silico protein structure modeling and site-directed mutagenesis to generate 16 AgamOBP1 protein analogues containing single point mutations of interest. Circular dichroism (CD) and ligand-binding assays provided data necessary to probe the effects of the point mutations on ligand binding and the overall structure of AgamOBP1. Far-UV CD spectra of mutated AgamOBP1 variants displayed both substantial decreases to ordered α-helix structure (up to22%) and increases to disordered α-helix structure(up to 15%) with only minimal changes in random coil (unordered) structure. In mutations Y54A, Y122A and W114Q, aromatic side chain removal from the binding site significantly reduced N-phenyl-1-naphthylamine binding. Several non-aromatic mutations (L15T, L19T, L58T, L58Y, M84Q, M84K, H111A, Y122A and L124T) elicited changes to protein conformation with subsequent effects on ligand binding. This study provides empirical evidence for the in silico predicted functions of specific amino acids in AgamOBP1 folding and ligand binding characteristics.
KW - 3D modeling
KW - Anopheles gambiae
KW - Circular dichroism spectroscopy
KW - Fluorescence spectroscopy
KW - Odorant Binding Protein
KW - Site directed mutagenesis
UR - http://www.scopus.com/inward/record.url?scp=84861792866&partnerID=8YFLogxK
U2 - 10.1016/j.bbapap.2012.04.011
DO - 10.1016/j.bbapap.2012.04.011
M3 - Article
C2 - 22564768
AN - SCOPUS:84861792866
SN - 1570-9639
VL - 1824
SP - 947
EP - 953
JO - Biochimica et Biophysica Acta - Proteins and Proteomics
JF - Biochimica et Biophysica Acta - Proteins and Proteomics
IS - 8
ER -